clinical trial · NCT01172691
Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts
Baylor Research Institute·phase2·completed·n = 23
Liver TransplantInhaled Nitric Oxide (iNO)Placebo Arm (Nitrogen)
brief summary
This study is being done to determine if patients receiving (iNO) will have increased liver function and less damage from IR than patients who do not receive (iNO).
started
Jul 1, 2010
primary completion
Jan 22, 2014
completion
Jan 22, 2014
last updated
Jan 28, 2026
official title
Randomized, Blinded, Controlled Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol